For Treatment Of Polycythemia Vera, FDA Approves Jakafi, A Targeted Therapy hematology, leukemia, meds, oncology, oral, precision medicine, targeted therapy, treatment as seen in Forbes The kinase inhibitor offers a new option for people with polycythemia vera, a condition for which few drugs have been available. Related
Why News About Thyroid Cancer Screening Doesn’t Apply To Breast Cancer Why News About Thyroid Cancer Screening Doesn’t Apply To Breast Cancer
For Treatment Of Polycythemia Vera, FDA Approves Jakafi, A Targeted Therapy For Treatment Of Polycythemia Vera, FDA Approves Jakafi, A Targeted Therapy
‘Lily,’ A Film About A Young Artist With Breast Cancer, And What’s Next In Her Life ‘Lily,’ A Film About A Young Artist With Breast Cancer, And What’s Next In Her Life